Neuroone Medical Technologies Corp
NASDAQ:NMTC
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Price:
1.12 USD
-3.45%
Market Closed
Updated:
May 12, 2024
Neuroone Medical Technologies Corp
Cost of Revenue
|
Neuroone Medical Technologies Corp
Cost of Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
Cost of Revenue
-$2.1m
|
CAGR 3-Years
-166%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Neuroone Medical Technologies Corp's Cost of Revenue?
Cost of Revenue
-2.1m
USD
-2.1m
USD
Based on the financial report for Dec 31, 2023, Neuroone Medical Technologies Corp's Cost of Revenue amounts to -2.1m USD.
What is Neuroone Medical Technologies Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-166%
-166%
Over the last year, the Cost of Revenue growth was -550%. The average annual Cost of Revenue growth rates for Neuroone Medical Technologies Corp have been -166% over the past three years .
You don't have any saved screeners yet
